John Still

**PharmaMetrics was acquired by Accel-KKR in April 2017 for an undisclosed sum to create the Market Access Segment of IntegriChain.*** ----------- PharmaMetrics offers multiple ways to optimize biopharma investments: Contract Operations Services Advisory Consulting Predictive Analytics Software Data Management & Reporting What we bring to the table is a team of creative thinkers with decades of experience in Biopharmaceutical Pricing Analytics, Managed Markets Analytics, Launch Strategy, and technology enabled Contract Operations (SaaS or as a Service). We partner with our clients to negotiate more profitable deals, automate existing contracting processes, advise on "Best Practices"​ and track contract performance with the goal of improving contract profit margins and optimizing rebate investments. Additionally, our proprietary software, called PharmaLytics, provides a unique approach to pre and post-deal analytics, combining disparate data sources to answer specific business questions quickly, in easy-to-use formats. PharmaLytics includes customer and product portfolio analysis, customer valuation, recommended discounts, predictive analytics, as well as financial forecasting and rebate accruals. Strategy. Solutions. Success. Our goal at PharmaMetrics is to be the best provider of managed markets contract operations, strategy, and predictive analytics software. We do that by listening to our customers to continuously enhance our tools to provide what they need to run a better, smarter, technology and data enabled business with greater cost-effectiveness. We deliver on our promises. Always.